Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Toronto

$14,775.00

Oxadiazole grafts in peptide macrocycles

EF 2016-17

Résumé
Dr. Yudin's group has developed a versatile approach to rapidly access structurally diverse macrocyclic peptides via a reaction between readily accessible components, namely, a linear peptide, aldehyde, and (N-isocyanimino) triphenylphosphorane (Pinc). A unique and enabling feature of this approach involves the formation of an unprecedented motif in the form of a contiguous non-amidated N-terminal amino group, variable aldehyde, and 1,3,4-oxadiazole triad inserted directly into the peptide backbone. This new linkage displays a remarkably well-conserved conformational geometry, independent of the peptidic or aldehyde components, and serves as an endocyclic control element that stabilizes turn motifs thereby promoting passive membrane permeability. This, in turn, facilitates oral bioavailability of oxadiazole-containing macrocycles. ß-Turns are present in a number of biologically active peptides, supporting the application of this methodology for the development of new therapeutics and biological probes. The primary application for Oxadiazole Grafts for Peptide Macrocytes has been preliminarily determined to be in the creation of novel molecules for commercialization or utilization by companies in the following spaces: therapeutics and pharmaceuticals, veterinary health sciences, agrochemicals and other applications. The main aim of the proposed market assessment is to evaluate the market potential of the proposed technology through assessment of market size, competitive landscape, barriers to entry, and market trends. Analysis will also be performed to assess potential factors affecting the commercialization of the technology, including issues regarding product adoption by end-users, product positioning, potential distribution channels, and regulatory factors.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
501983-2016
Name nom
Yudin, Andrei
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
14775
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Oxadiazole grafts in peptide macrocycles
Keyword
NSERC
Application summary
Dr. Yudin's group has developed a versatile approach to rapidly access structurally diverse macrocyclic peptides via a reaction between readily accessible components, namely, a linear peptide, aldehyde, and (N-isocyanimino) triphenylphosphorane (Pinc). A unique and enabling feature of this approach involves the formation of an unprecedented motif in the form of a contiguous non-amidated N-terminal amino group, variable aldehyde, and 1,3,4-oxadiazole triad inserted directly into the peptide backbone. This new linkage displays a remarkably well-conserved conformational geometry, independent of the peptidic or aldehyde components, and serves as an endocyclic control element that stabilizes turn motifs thereby promoting passive membrane permeability. This, in turn, facilitates oral bioavailability of oxadiazole-containing macrocycles. ß-Turns are present in a number of biologically active peptides, supporting the application of this methodology for the development of new therapeutics and biological probes. The primary application for Oxadiazole Grafts for Peptide Macrocytes has been preliminarily determined to be in the creation of novel molecules for commercialization or utilization by companies in the following spaces: therapeutics and pharmaceuticals, veterinary health sciences, agrochemicals and other applications. The main aim of the proposed market assessment is to evaluate the market potential of the proposed technology through assessment of market size, competitive landscape, barriers to entry, and market trends. Analysis will also be performed to assess potential factors affecting the commercialization of the technology, including issues regarding product adoption by end-users, product positioning, potential distribution channels, and regulatory factors.